Market Tracker

01/16 5:46am ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.166
Delayed Data
As of Jan 13
 +0.006 / +3.75%
Today’s Change
0.13
Today|||52-Week Range
0.42
+16.98%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.16
Today’s open0.17
Day’s range0.16 - 0.17
Volume862,366
Average volume (3 months)1,265,660
Market cap$39.4M
Dividend yield--
Data as of 4:02pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)+27.27%
Earnings growth (this year)+18.75%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.75

Competitors

 Today’s
change
Today’s
% change
TPIVTapImmune Inc-0.18-3.71%
XBIOXenetic Biosciences ...-0.01-0.15%
FCSCFibrocell Science In...-0.01-0.60%
THLDThreshold Pharmaceut...+0.04+8.50%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateMarch 21, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$14.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts